Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

24.98USD
6:23pm GMT
Change (% chg)

$0.16 (+0.64%)
Prev Close
$24.82
Open
$24.92
Day's High
$25.44
Day's Low
$24.80
Volume
46,711
Avg. Vol
151,660
52-wk High
$35.55
52-wk Low
$21.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.251
Sep '18 0.00 -0.377
Jun '18 0.00 -1.193
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 6 0.00 0.00 0.00 --
Quarter Ending Jun-19 6 0.00 0.00 0.00 --
Year Ending Dec-19 6 0.00 0.00 0.00 --
Year Ending Dec-20 6 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 6 -0.43 -0.39 -0.58 --
Quarter Ending Jun-19 6 -0.51 -0.46 -0.63 --
Year Ending Dec-19 6 -2.12 -2.02 -2.50 --
Year Ending Dec-20 6 -2.55 -2.20 -2.93 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.73 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) -- 10.19 5.27
Price to Tangible Book (MRQ) -- 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.73 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.14 47.70
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.50 2.98
LT Debt to Equity (MRQ) -- 19.47 11.35
Total Debt to Equity (MRQ) -- 32.15 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.45 12.43
Operating Margin (TTM) -- -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.93 8.02
Pre-Tax Margin (TTM) -- -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.72 8.31
Net Profit Margin (TTM) -- -182.45 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.11 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.51 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,655,763 820,310,835
Net Income/Employee (TTM) -- 513,903 92,854,950
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.37 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -- 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -- 10.02 15.24
Return on Equity - 5 Yr. Avg. -- 8.30 16.41

Performance for Allogene Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 99
13 Week -- -- -- 95
26 Week -- -- -- 98
52 Week -- -- -- 71
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.90%
# of Holders: 113
Total Shares Held: 63,044,350
3 Mo. Net Change: 62,305,873
# New Positions: 99
# Closed Positions: 0
# Increased Positions: 105
# Reduced Positions: 5
# Net Buyers: 100
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.